Clinical Trial Update: START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update of PeptiCRAd-1 reports safety signals and anti-tumor activity across multiple cancers; trial status is ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Melanoma
• Myxoid Liposarcoma
• Non-small Cell Lung Cancer
• Osteosarcoma
• Sarcoma
• Synovial Sarcoma
• Triple-negative Breast Cancer

Drugs mentioned

• PeptiCRAd-1

Snippet

Sponsor: Valo Therapeutics Oy | Conditions: Melanoma (Skin), Triple-Negative Breast Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING